Ok Biotech Financials
| 4155 Stock | 22.30 0.10 0.45% |
4155 |
Understanding current and past Ok Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ok Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Ok Biotech's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Ok Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ok Biotech Co. Check Ok Biotech's Beneish M Score to see the likelihood of Ok Biotech's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0004155007 |
| Business Address | No 91, Gongdao |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.okbiotech.com |
| Phone | 886 3 516 0258 |
You should never invest in Ok Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 4155 Stock, because this is throwing your money away. Analyzing the key information contained in Ok Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Ok Biotech Key Financial Ratios
There are many critical financial ratios that Ok Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ok Biotech reports annually and quarterly.| Return On Equity | 0.0799 | |||
| Return On Asset | 0.0155 | |||
| Beta | 0.38 | |||
| Z Score | 4.2 | |||
| Last Dividend Paid | 1.0 |
4155 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ok Biotech's current stock value. Our valuation model uses many indicators to compare Ok Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ok Biotech competition to find correlations between indicators driving Ok Biotech's intrinsic value. More Info.Ok Biotech Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.19 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ok Biotech Co is roughly 5.15 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ok Biotech's earnings, one of the primary drivers of an investment's value.Ok Biotech Systematic Risk
Ok Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ok Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Ok Biotech correlated with the market. If Beta is less than 0 Ok Biotech generally moves in the opposite direction as compared to the market. If Ok Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ok Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ok Biotech is generally in the same direction as the market. If Beta > 1 Ok Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Ok Biotech November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ok Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ok Biotech Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ok Biotech Co based on widely used predictive technical indicators. In general, we focus on analyzing 4155 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ok Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 7.54 | |||
| Value At Risk | (2.27) | |||
| Potential Upside | 2.42 |
Additional Tools for 4155 Stock Analysis
When running Ok Biotech's price analysis, check to measure Ok Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ok Biotech is operating at the current time. Most of Ok Biotech's value examination focuses on studying past and present price action to predict the probability of Ok Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ok Biotech's price. Additionally, you may evaluate how the addition of Ok Biotech to your portfolios can decrease your overall portfolio volatility.